Opko Health (OPK) Gross Profit (2010 - 2026)

Opko Health (OPK) has 17 years of Gross Profit data on file, last reported at $80.0 million in Q2 2026.

• Quarterly Gross Profit rose 61.97% year-over-year to $80.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $239.7 million (down 25.0% YoY) and the FY2025 annual result came in at $205.9 million, down 5.75% from the prior year.
• Gross Profit improved to $80.0 million in Q2 2026, from $45.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $152.4 million in Q2 2023 to a low of -$111.6 million in Q1 2023.
• A 5-year average of $57.2 million and a median of $51.6 million in 2022 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2023 — Gross Profit tumbled 218.64% — and 2024, when it surged 137.71%.
• Tracing OPK's Gross Profit over 5 years: stood at -$9.4 million in 2022, then plunged by 218.64% to -$30.0 million in 2023, then jumped by 546.13% to $133.9 million in 2024, then sank by 52.17% to $64.0 million in 2025, then grew by 24.98% to $80.0 million in 2026.
• The last three Gross Profit figures came in at $80.0 million (Q2 2026), $45.8 million (Q1 2026), and $64.0 million (Q4 2025), per Business Quant data.